Outcome of Board Meeting held for consideration and approval of the Consolidated and Standalone unaudited Financial Results for the half year ended 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shivam Chemicals' Board approved H1 FY26 (Apr–Sep 2025) results with strong year-on-year growth. Consolidated revenue from operations rose to ₹13,166.78 lakhs from ₹9,441.57 lakhs, a jump of about 39.5%. Profit before tax grew nearly 2.9x to ₹252.55 lakhs and profit after tax more than tripled to ₹196.51 lakhs (vs ₹58.02 lakhs), translating to EPS of ₹1.16 versus ₹0.34. On a standalone basis, revenue climbed about 45.6% to ₹12,486.95 lakhs and PAT rose to ₹154.60 lakhs from ₹87.82 lakhs. Statutory auditor PSRD & Co. issued an unmodified (clean) review opinion on both consolidated and standalone results.
Sharp revenue and profit growth alongside a clean auditor opinion is a positive signal for shareholders, indicating strong operational momentum. However, short-term borrowings nearly doubled (₹1,036 → ₹2,010 lakhs consolidated) and standalone operating cash flow turned negative, which investors should watch for working-capital stress despite the healthy bottom-line growth.